Rotigotine Impurity 23 HCl

Rotigotine Impurity 23 HCl, with the CAS number 102121-00-6, is a highly specialized and purified chemical compound that plays a crucial role in pharmaceutical research and development. This Parkison treatment-related compound is a valuable asset for scientists and researchers exploring innovative solutions for neurological disorders.

As a key impurity associated with the active pharmaceutical ingredient (API) Rotigotine, this compound offers a unique opportunity to study the potential impact of impurities on drug efficacy and safety. Its meticulous synthesis and rigorous quality control ensure that researchers have access to a reliable and well-characterized chemical entity to support their investigations.

The chemical structure of Rotigotine Impurity 23 HCl, with a molecular formula of C19H25NOS·HCl and a molecular weight of 315.48 g/mol, provides a distinct fingerprint for identification and analysis. This compound's purity, typically exceeding 95%, guarantees consistent and reproducible results in various experimental settings.

Unlocking the Potential of Rotigotine Impurity 23 HCl

Rotigotine Impurity 23 HCl finds its primary application in the field of Parkinson's disease research. As a structural analog of the approved drug Rotigotine, this compound offers researchers a valuable tool to explore the impact of impurities on the pharmacological profile of Parkinson's treatments. By studying the effects of Rotigotine Impurity 23 HCl, scientists can gain crucial insights into the drug's mechanism of action, potential side effects, and overall therapeutic efficacy.

Beyond its role in Parkinson's research, Rotigotine Impurity 23 HCl may also find applications in the development of other neurological therapies. Its unique chemical structure and properties can be leveraged to investigate the relationship between impurities and the efficacy of drugs targeting various central nervous system disorders, such as Alzheimer's disease, Huntington's disease, or even mood disorders.

Researchers can utilize Rotigotine Impurity 23 HCl to conduct a wide range of studies, including but not limited to:

• Comparative analysis of the pharmacokinetic and pharmacodynamic profiles of Rotigotine and its impurities
• Evaluation of the impact of Rotigotine Impurity 23 HCl on the drug's therapeutic potential and safety
• Exploration of the structural-activity relationships between Rotigotine and its impurities
• Development of analytical methods for the detection and quantification of Rotigotine impurities
• Investigations into the potential cross-reactivity or interference of Rotigotine Impurity 23 HCl with other neurological drugs or biomarkers

Ensuring Quality and Safety

Rotigotine Impurity 23 HCl is intended for laboratory use only and is not meant for human consumption. Appropriate safety precautions must be taken when handling this compound, including the use of personal protective equipment (PPE) and working in a well-ventilated area. Researchers should consult the relevant safety data sheets (SDS) and follow established protocols to ensure the safe and responsible use of this chemical.

For long-term storage, Rotigotine Impurity 23 HCl should be kept under the recommended conditions to maintain its stability and purity. Proper storage and handling practices are crucial to preserving the integrity of this valuable research tool and enabling consistent, reliable results in scientific investigations.

Unlocking New Possibilities in Pharmaceutical Research

Rotigotine Impurity 23 HCl represents a unique opportunity for researchers to delve deeper into the complexities of drug development and the impact of impurities on therapeutic efficacy. By leveraging this specialized compound, scientists can uncover valuable insights that may lead to the optimization of Parkinson's treatments and the exploration of novel neurological therapies.